Open Label Study of 8 vs. 12 Weeks of Ledipasvir / Sofosbuvir in Genotype 6 Treatment Na ï ve or Experienced Patients

Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naïve or Experienced Patients American Journal of Gastroenterology 112, 1824 (December 2017). doi:10.1038/ajg.2017.399 Authors: Mindie H Nguyen, Huy Trinh, Son Do, Thuan Nguyen, Pauline Nguyen & Linda Henry
Source: The American Journal of Gastroenterology - Category: Gastroenterology Authors: Source Type: research
More News: Gastroenterology | Study